Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanoma.

about

Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma The prognostic value of Ki67 in ovarian high-grade serous carcinoma: an 11-year cohort study of Chinese patients.

P2860

Q41558364-6D59182A-FF8B-48CE-8FEF-3A492FAB6147 Q47111746-8110496B-3902-48F0-82EC-6BA42FF9E82F

P2860

Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanoma.

Item

http://www.wikidata.org/entity/Q38381558

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Molecular markers to complemen ...... isk locally invasive melanoma.

@en

type

Item

label

Molecular markers to complemen ...... isk locally invasive melanoma.

@en

prefLabel

Molecular markers to complemen ...... isk locally invasive melanoma.

@en

P1476

Molecular markers to complemen ...... isk locally invasive melanoma.

@en

P2093

Adele C Green

http://www.w3.org/2001/XMLSchema#string

Andrew Barbour

http://www.w3.org/2001/XMLSchema#string

Casey J Rowe

http://www.w3.org/2001/XMLSchema#string

Fiona Tang

http://www.w3.org/2001/XMLSchema#string

Maria Celia B Hughes

http://www.w3.org/2001/XMLSchema#string

Maryrose Malt

http://www.w3.org/2001/XMLSchema#string

Nicholas K Hayward

http://www.w3.org/2001/XMLSchema#string

P2860

Final version of 2009 AJCC melanoma staging and classification

Clinical and biological determinants of melanoma progression: Should all be considered for clinical management?

Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria.

Prognostic survival model for people diagnosed with invasive cutaneous melanoma.

Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.

Melanoma prognosis: a REMARK-based systematic review and bioinformatic analysis of immunohistochemical and gene microarray studies.

Review and cross-validation of gene expression signatures and melanoma prognosis.

Sentinel lymph node biopsy in melanoma: controversies and current guidelines.

No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.

P304

664-672

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.30085

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P50

Kiarash Khosrotehrani

Mathieu Rodero

Duncan Lambie

Mark Smithers

P577

2016-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26990817

http://www.w3.org/2001/XMLSchema#string

Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanoma.

about

P2860

P2860

Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698